About QV Bioelectronics
QV Bioelectronics is a company based in Manchester (United Kingdom) founded in 2019 by Richard Fu and Christopher Bullock.. QV Bioelectronics has raised $9.63 million across 5 funding rounds from investors including UK Research and Innovation, Northern Gritstone and Elbow Beach. The company has 6 employees as of October 31, 2021. QV Bioelectronics offers products and services including GRACE. QV Bioelectronics operates in a competitive market with competitors including Novocure, Ablatus Therapeutics, Mirai Medical, SonALAsense and Pulse Biosciences, among others.
- Headquarter Manchester, United Kingdom
- Employees 6 as on 31 Oct, 2021
- Founders Richard Fu, Christopher Bullock
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Qv Bioelectronics Ltd.
- Date of Incorporation 07 Oct, 2018
- Jurisdiction NETHER ALDERLEY, CHESHIRE, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.63 M (USD)
in 5 rounds
-
Latest Funding Round
$6.05 M (USD), Series A
Jan 21, 2026
-
Investors
UK Research and Innovation
& 9 more
-
Employee Count
6
as on Oct 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of QV Bioelectronics
QV Bioelectronics offers a comprehensive portfolio of products and services, including GRACE. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Implanted device for electric field therapy in glioblastoma treatment
Unlock access to complete
Unlock access to complete
Funding Insights of QV Bioelectronics
QV Bioelectronics has successfully raised a total of $9.63M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $6.05 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $6.1M
-
First Round
First Round
(29 Oct 2019)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2026 | Amount | Series A - QV Bioelectronics | Valuation | PXN Ventures | |
| Apr, 2023 | Amount | Grant - QV Bioelectronics | Valuation |
investors |
|
| Jan, 2023 | Amount | Seed - QV Bioelectronics | Valuation | Science Angel Syndicate , Fink Family Office |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in QV Bioelectronics
QV Bioelectronics has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include UK Research and Innovation, Northern Gritstone and Elbow Beach. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment firm focused on investing in science and technology firms
|
Founded Year | Domain | Location | |
|
Venture capital investments are made in climate technology solutions.
|
Founded Year | Domain | Location | |
|
Venture capital and accelerator services are provided across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by QV Bioelectronics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - QV Bioelectronics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Qv Bioelectronics Comparisons
Competitors of QV Bioelectronics
QV Bioelectronics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novocure, Ablatus Therapeutics, Mirai Medical, SonALAsense and Pulse Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for solid tumors are developed via Tumor Treating Fields.
|
|
| domain | founded_year | HQ Location |
Develops innovative devices for bimodal electric tissue ablation.
|
|
| domain | founded_year | HQ Location |
Mirai Medical is focused on transforming gastrointestinal disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for cancer and neurological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Nano-Pulse Electro-Signaling technology is developed for targeted cellular disruption.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Qv Bioelectronics
Frequently Asked Questions about QV Bioelectronics
When was QV Bioelectronics founded?
QV Bioelectronics was founded in 2019.
Where is QV Bioelectronics located?
QV Bioelectronics is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Is QV Bioelectronics a funded company?
QV Bioelectronics is a funded company, having raised a total of $9.63M across 5 funding rounds to date. The company's 1st funding round was a Seed of $2.43M, raised on Oct 29, 2019.
How many employees does QV Bioelectronics have?
As of Oct 31, 2021, the latest employee count at QV Bioelectronics is 6.
What does QV Bioelectronics do?
QV Bioelectronics was founded in 2019 and is based in Manchester, United Kingdom. Operations focus on the medical devices sector, where electrotherapy solutions for oncology are developed and manufactured. The flagship product, GRACE, is an implanted device designed to deliver electric field therapy directly to tumor resection margins, targeting glioblastoma multiforme recurrence sites. Activities center on advancing treatments for brain tumors through implantable technologies.
Who are the top competitors of QV Bioelectronics?
QV Bioelectronics's top competitors include Novocure, Pulse Biosciences and SonALAsense.
What products or services does QV Bioelectronics offer?
QV Bioelectronics offers GRACE.
Who are QV Bioelectronics's investors?
QV Bioelectronics has 10 investors. Key investors include UK Research and Innovation, Northern Gritstone, Elbow Beach, SOSV, and Catapult Ventures.